← Eichor
Study identifier: NCT05967949 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Retrospective Clinical Study on the First-line Maintenance Treatment of PTCL With Chidamide.

Condition: PTCL  ·  Sponsor: The First Affiliated Hospital with Nanjing Medical University

PhaseN/A
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The efficacy and safety of chidamide in first-line maintenance therapy for PTCL will be assessed through a retrospective case analysis.

This description comes directly from the study's public registry record.

Talk to the study team

wei xu  ·  +862568302182  ·  xuwei10000@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Hematological Department, People's Hospital of Jiangsu ProvinceNanjing, Jiangsu, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05967949